Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To describe the patient characteristics, indications, and clinical outcomes of home high flow nasal cannula (HFNC) among pediatric patients. To evaluate secular trends in home HFNC initiation between 2013 and 2022.
Methods: A retrospective review of all children on home HFNC between 2013 and 2023 was conducted at a tertiary care pediatric hospital in Ontario, Canada. Descriptive statistics were used to summarize results and identify indications for home HFNC initiation. Mann-Kendall Trend test was used to assess trends in HHF initiation between 2013 and 2022.
Results: A total of 35 patients, ages 6 months-14 years old, were started on home HFNC between 2013 and 2023. HFNC initiation increased over time, from 0 patients in 2013-2016 to nine patients per year in 2021 and 2022 (p < .001). Home HFNC was almost exclusively prescribed for children with multisystem conditions, 77% with an underlying genetic disorder, and 77% with prior home feeding tube use. Most children (83%) had multiple indications leading to initiation of home HFNC. The main indications included the following: (i) upper airway obstruction (66%), (ii) clearance of retained CO (57%), (iii) increased work of breathing without sleep-disordered breathing (29%), (iv) promotion of secretion clearance/plastic bronchitis (29%), and (v) palliative care (14%). In addition, 37% did not tolerate a previous trial of Continuous/Bi-Level Positive Airway Pressure. Complications were rare, with only two children developing epistaxis requiring an emergency department visit and 4 children requiring escalation in home respiratory support to CPAP or BiPAP.
Conclusion: HFNC is increasingly being initiated among children in the home setting for varied indications. Preliminary data suggests few complications and a need for escalation of therapy with home HFNC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jhm.13571 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
High-Flow Nasal Cannula in Weaning Patients from Mechanical Ventilation in Head and Neck Surgery: Retrospective Study.
Life (Basel)
August 2025
Department of Women, Child, General and Specialistic Surgery, University of Campania "L. Vanvitelli", 80138 Naples, Italy.
Patients undergoing head and neck surgery with free flap reconstruction are at a high risk for postoperative respiratory complications, including hypoxemia. Conventional oxygen therapy (COT) and non-invasive ventilation (NIV) may be poorly tolerated or contraindicated due to anatomical limitations. High-Flow Nasal Cannula (HFNC) therapy represents a promising alternative, offering better humidification, comfort, and oxygenation.
View Article and Find Full Text PDFIs high-flow nasal oxygen as effective as non-invasive ventilation in acute cardiogenic pulmonary Edema?
Am J Emerg Med
August 2025
Emergency Medicine, Marmara University School of Medicine, Department of Emergency Medicine, Istanbul, Turkey.
Objective: Acute cardiogenic pulmonary edema (ACPE) is a significant cause of emergency department (ED) visits due to dyspnea. Non-invasive ventilation (NIV) is currently the recommended first-line treatment for respiratory failure secondary to ACPE. The aim of this study is to compare the effectiveness of high-flow nasal cannula (HFNC) and NIV in improving respiratory rate (RR) and other clinical outcomes in adult patients presenting to the ED with ACPE.
View Article and Find Full Text PDFHigh-flow nasal cannula oxygen therapy improves respiratory parameters compared to conventional oxygen therapy in dogs with presumed noncardiogenic pulmonary edema.
J Am Vet Med Assoc
August 2025
1Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
Objective: To compare the clinical efficacy of high-flow nasal cannula (HFNC) oxygen therapy and conventional oxygen therapy (COT) in dogs with noncardiogenic pulmonary edema (NCPE), focusing on respiratory parameters and survival outcomes.
Methods: This retrospective observational cohort study reviewed cases from a veterinary teaching hospital between September 2022 and September 2024. Dogs were identified through electronic medical records and included if they met clinical criteria for NCPE, excluding those with cardiac or aspiration-related causes.
Evaluation of prognostic factors for high-flow nasal cannula therapy failure in infants with bronchiolitis: a prospective study.
Arch Pediatr
August 2025
Department of Pediatrics, Fattouma Bourguiba University Hospital, Monastir, Tunisia; University of Monastir, Monastir, Tunisia.
Objective: This study aims to identify factors associated with High-flow nasal cannula (HFNC) therapy failure in infants with moderate to severe bronchiolitis to personalize management and optimize outcomes.
Methods: A prospective cohort study was conducted from September 2021 to March 2023 in a pediatric intensive care unit. Infants aged 0-12 months with bronchiolitis requiring HFNC were included, excluding those with prior ventilation, tracheostomy, uncorrected cyanotic congenital heart disease, or chronic respiratory/neuromuscular conditions.
Respiratory management of critically ill pneumocystis pneumonia patients: a multicenter retrospective study.
Ann Intensive Care
August 2025
Department of Infectious Diseases, INSERM, University Hospital of Nantes and Centre d'Investigation Clinique 1413, Nantes, France.
Background: Pneumocystis jirovecii pneumonia (PjP) is a rising cause of acute respiratory failure in immunocompromised patients, often requiring Intensive Care Unit (ICU) admission. However, optimal ventilatory strategies remain unclear.
Methods: For the present study, we conducted an ancillary analysis of the PRONOCYSTIS study, a large multicenter cohort of PjP patients.